outlook capit catalyst
key stori
tick ests/po outlook await capit catalyst
yesterday provid initi guidanc updat market sale
davita medic group dmg plan use proce dva oper incom
guidanc bracket est/consensu came
expect midpoint although repres signific growth y/i impli
op inc growth normal cite weaker expect
volum commerci price pressur flat/down slightli wage growth rate
growth howev posit expect stabl commerci mix
activ work toward dmg sale close disappoint
outlook view valuat compel see potenti upsid signific
capit catalyst estim could repurchas third market cap
meet leverag target lower estim po due lower outlook
reaffirm buy rate see upsid capit deploy new po
base ebitda vs previous weaker fundament
fundament pressur still grow
dva treatment growth guidanc non-acquir limit tuck-
acquisit lower expect meanwhil made bearish commerci
price commentari note see signific pressur network
high rate outlier partial off-set modest rate increas larg major
patient howev note consist lower exposur high
rate outlier exposur lower today nine year ago final see
wage growth similar provid rate growth
sourc margin pressur despit keep cost flat normal
base exclud one-tim item impli op inc grow midpoint
unh optum activ work toward dmg deal close feder
trade commiss ftc review on-going although note govern
shutdown slow progress time within manag control view
dmg deal close key catalyst use proce pay debt
like launch new debt deal could put capit work repurchas
much third market cap next month
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
davita inc lead dialysi provid
unit state compani oper
outpati clinic us serv
patient also oper countri
outsid us
sale davita medic group dmg
posit use bulk proce
share repurchas still pay debt
make increment invest
health care servic outsid dialysi
po base ebitda estim around high end
stand-alon histor rang ebitda dmg sale allow
focu core dialysi busi deploy capit
upsid risk po commerci mix better expect
reimburs better expect make chang third
downsid risk po commerci price pressur could continu
potenti commerci mix pressur manag care vast major dialysi
kevin fischbeck cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us facil hospit manag healthcar coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
